Enter assignee name

% Expired Patents = 60.0

CIPO Patents = 1

EPO Patents = 3

Forward Citations = 133

Loading Chart...

9 inventors (with patents filed for the assignee):

Shih-Yao Lin (10 out of 26 patents)

Rong-Hwa Lin (7 out of 20 patents)

Yu-Ying Tsai (5 out of 7 patents)

4. Leewen Lin (5 out of 5 patents)

5. Chiu-Chen Huang (4 out of 12 patents)

6. Yu-Chi Hsieh (4 out of 5 patents)

7. Shu-Hua Lee (3 out of 4 patents)

8. Feng-Lin Chiang (1 out of 2 patents)

9. Li-An Hu (1 out of 1 patent)

10 patents: Sort by Forward Citations

1. 10472422 - Tetravalent anti-PSGL-1 antibodies and uses thereof (2019-11-12),

2. 9950077 - Anti-folate receptor alpha (FRA) antibody-drug conjugates and methods of using thereof (2018-04-24),

3. 9943610 - Hydrophilic self-immolative linkers and conjugates thereof (2018-04-17),

4. 9408923 - Hydrophilic self-immolative linkers and conjugates thereof (2016-08-09),

5. 9334329 - Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same (2016-05-10),

6. 9193794 - Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same (2015-11-24),

7. 9089614 - Hydrophilic self-immolative linkers and conjugates thereof (2015-07-28),

8. 8568718 - Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same (2013-10-29),

9. 7982017 - Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same (2011-07-19),

10. 7674605 - Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same (2010-03-09),

Bioalliance C.v. is a biotechnology company based in Amsterdam, specializing in the development of innovative solutions for healthcare and life sciences. The organization focuses on harnessing advanced biotechnological methods to create products that address unmet medical needs, particularly in the fields of drug delivery and therapeutic applications. With a commitment to research and development, Bioalliance aims to contribute significantly to the advancement of medical technologies and improve patient outcomes globally.

Profile summary based on public USPTO records.